Latest news
Loading news…
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
RayzeBio on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
RayzeBio was acquired by Bristol-Myers Squibb in 2023.
Total Funding
$418M
Funding Rounds
4
Last Funding
Acquisitions
0
Monthly Visits
Contacts
119
About RayzeBio
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
- Diversity spotlight
- Women Founded
RayzeBio Funding Rounds
4 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–4 of 4Show
Page 1 / 1
RayzeBio Key People
Chief Medical Officer
Scientific Founder, Chief Technology Officer, Advisor
119
professional contacts at RayzeBio
Contact execs at RayzeBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about RayzeBio
People who checked this page also checked these
Browse the full Acquirezy directory.